K8콢

Դ̿γߣ 

ҹ꽲вٯҡ»վ꽲վɶطǿꁶһûϸȥһѵ˳㵴滹е㡰ζ

ɶȡζе˼

ͼƬ

ҿվɶ󾰵ҪǻᡰTTһȤЩϽ֡ҰζſҡȱͷβСζһžǡԼˡ꽲؁Ȥ

һмСֹζӣͷʱʽڹҽطԭǸͷŇӣ

͵͵꽲мС̯糿ȥŻڼҰϸݹζֵùֺŇӣȥȻʱܾ̯

ġ桱Ҫʱ䣡

ϲՇվҲмƩ糿ʱߴůůɫҰζ

һǻƻʱϵְ̫Ұֻijʱ⡱ζ

ͼƬ ͵͵꽲иͷַС˻Ҫеסײǽϻǰ̱껭ӣ

ܻʇӣǾֵֵȥ

ҿʱԣぶһ䡰ζȥǺõҪʱ뿴ɶÁ

ؽ꽲ǁ

ͼƬ

ǩ»վ桢Ͻζͷվܺ

ַ¥Ʒ̳ۡ

źгչͼӡڡҪΪѡƷΪҪӡṩܡҪԴ󸺺ɡϵӡҪܼߵĴӡƷʺͱܼԻ᳡ĸʵʱļӦϵͳ칫ʵʱЭͬÿһϸڶ뾫һӡ֤˱ͼƷʸЧſɿ׿ԽƷʵˡҪñͼҪñͼ

̫ԭڽ

131չ˾2025ҵԤԤʵ־68.00Ԫ78.00Ԫͬȱ任Ϊ51.00%~73.00%

ɽ·ƽֵĿܼ

޸֮һ΢ʱܹͨϸֳָܻȻܺõġԵлЧϰ֬ԸףMetabolic dysfunction-associated steatohepatitis, MASHԲѬȾþƾʱ޸ƾͻʧ̫Ծ޸̻ᵼϸʣExtracellular matrixĴڳԭĸ֯𽥱ӲγɸάLiver fibrosisһ̲ӸԤתӲΰ

վͼ